Results 61 to 70 of about 20,563 (225)

Not COVID-19, Don’t Overlook Pneumocystis in Patients on Gefitinib!

open access: yesCurrent Oncology, 2021
An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia.
Jérémy Barben   +4 more
doaj   +1 more source

Increased mortality in hematological malignancy patients with acute respiratory failure from undetermined etiology : a Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologique (Grrr-OH) study [PDF]

open access: yes, 2016
Background: Acute respiratory failure (ARF) is the most frequent complication in patients with hematological malignancies and is associated with high morbidity and mortality.
Azoulay, Elie   +19 more
core   +2 more sources

The Role of Belatacept‐Use and Senescence on Infectious and Mortality Complications After Kidney Transplantation

open access: yesTransplant Infectious Disease, EarlyView.
ABSTRACT Introduction Studies evaluating the incidence of infections after belatacept as a substitute for calcineurin inhibitors (CNI) or antimetabolite in kidney transplant (KT) yielded conflicting results. We compared infectious outcomes after belatacept‐use to no belatacept‐use in KT recipients.
Hareesh Singam   +5 more
wiley   +1 more source

Late presentation of Pneumocystis jirovecii pneumonia after renal transplant: A case report

open access: yesMedical Mycology Case Reports, 2018
The highest risk of opportunistic infections is from 1 to 6 months post-transplant. We report a rare case of Pneumocystis jirovecii pneumonia in a renal transplant recipient only on maintenance immunosuppression eleven years after transplant without ...
Prithiv Prasad   +2 more
doaj   +1 more source

Triplex Hybridization-Based Nanosystem for the Rapid Screening of Pneumocystis Pneumonia in Clinical Samples

open access: yesJournal of Fungi, 2020
Pneumocystis pneumonia (PcP) is a disease produced by the opportunistic infection of the fungus Pneumocystis jirovecii. As delayed or unsuitable treatments increase the risk of mortality, the development of rapid and accurate diagnostic tools for PcP are
Luis Pla   +9 more
doaj   +1 more source

A case of acanthosis nigricans in a HIV-infected patient [PDF]

open access: yes, 2020
Background: To date, very little information is available concerning the relationship between acanthosis nigricans (AN) and infection with human immunodeficiency virus type 1 (HIV-1).
De Vincentiis, Ludovica   +5 more
core   +1 more source

Telitacicept Combined With Glucocorticoids as Initial Therapy for Moderate IgA Vasculitis Nephritis With Concurrent Pulmonary Infection in Children: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
This graphical abstract depicts the clinical course of a 14‐year‐old male with moderate IgAV‐N treated with telitacicept combined with glucocorticoids as initial therapy. Rapid glucocorticoid tapering, normalized renal function, and continuous remission of proteinuria and hematuria were achieved.
Jiayi Li   +7 more
wiley   +1 more source

Genetic Polymorphisms of Superoxide Dismutase Locus of Pneumocystis jirovecii in Spanish Population

open access: yesFrontiers in Public Health, 2019
Objective:Pneumocystis pneumonia remains a major opportunistic infection in immunocompromised patients worldwide. Colonization with Pneumocystis jirovecii has recently gained attention as an important issue for understanding the complete cycle of human ...
Rubén Morilla   +12 more
doaj   +1 more source

Clinical characteristics of pneumonia in non-HIV patients and prognostic factors including microbiological genotypes [PDF]

open access: yes, 2011
Background The number of patients with non-HIV Pneumocystis pneumonia (PCP) is increasing with widespread immunosuppressive treatment. We investigated the clinical characteristics of non-HIV PCP and its association with microbiological ...
Yasufumi Matsumura   +10 more
core   +1 more source

An Unusual Case Presentation on Docetaxel Induced Lung Injury

open access: yesClinical Case Reports, Volume 14, Issue 4, April 2026.
ABSTRACT Docetaxel can rarely cause acute interstitial lung injury early in therapy. New‐onset cough, fever, or dyspnea after chemotherapy should prompt immediate evaluation, exclusion of infection, and high‐resolution CT imaging. Early drug withdrawal and timely corticosteroid therapy can result in rapid clinical recovery and prevent serious morbidity.
Soorej Balan Kaliyath   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy